0

GSK bets on lift from new lung drugs ahead of Advair’s last gasp

Reuters: Company News Reuters: Company News

LONDON, May 18 (Reuters) - GlaxoSmithKline is putting more marketing muscle behind its new lung drugs and is looking for a sales boost as top respiratory experts gather to analyse clinical trials data at a meeting in San Diego this weekend.

Reuters: Company News

Leave a Reply